Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy

被引:99
作者
Cai, Lu
机构
[1] Univ Louisville, Dept Med, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Radiat Oncol, Louisville, KY 40202 USA
[3] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA
[4] Wenzhou Med Coll, Sch Pharm, Wenzhou 325035, Peoples R China
[5] Jilin Univ, Dept Hematol, Teaching Hosp 1, Changchun 130021, Peoples R China
[6] Jilin Univ, Dept Oncol, Teaching Hosp 1, Changchun 130021, Peoples R China
关键词
diabetic cardiomyopathy; metallothionein; reactive oxygen species; reactive nitrogen species; oxidative stress; nitrative stress; free radicals;
D O I
10.1016/j.freeradbiomed.2006.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic cardiomyopathy has become a major contributor to the increased mortality of diabetic patients. Although the development and progression of diabetic cardiomyopathy are considered to be associated with diabetes-derived oxidative stress, the precise mechanisms for and effectively preventive approaches to diabetic cardiomyopathy remain to be explored. Recent studies showed that reactive oxygen or nitrogen species (ROS/RNS) not only play a critical role in the initiation of diabetic cardiomyopathy, but also play an important role in physiological signaling. Therefore, this review will first discuss the dual roles of ROS/RNS in the physiological signaling and pathogenic remodeling leading to cardiomyopathy under diabetic conditions. The significant prevention of diabetic cardiomyopathy by metallothionein (NIT) as a potent and nonspecific antioxidant will be also summarized. It is clearly revealed that although dual roles of peroxynitrite-nitrated proteins have been indicated under both physiological and pathogenic conditions, suppression of nitrative damage by NIT in the diabetic heart is the major mechanism responsible for its prevention of diabetic cardiomyopathy. Finally the potential for clinical enhancement of the cardiac NIT expression to prevent or delay the occurrence of cardiomyopathy in diabetic patients will also be addressed. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:851 / 861
页数:11
相关论文
共 116 条
  • [1] INHIBITION OF HYDROXYL-RADICAL-GENERATED DNA-DEGRADATION BY METALLOTHIONEIN
    ABEL, J
    DERUITER, N
    [J]. TOXICOLOGY LETTERS, 1989, 47 (02) : 191 - 196
  • [2] Al-Maroof RA, 2006, SAUDI MED J, V27, P344
  • [3] Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression
    Alp, NJ
    Mussa, S
    Khoo, J
    Cai, SJ
    Guzik, T
    Jefferson, A
    Goh, N
    Rockett, KA
    Channon, KM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (05) : 725 - 735
  • [4] Awasthi S, 2006, J PEDIATR GASTR NUTR, V42, P300
  • [5] Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion
    Baldus, S
    Heitzer, T
    Eiserich, JP
    Lau, D
    Mollnau, H
    Ortak, M
    Petri, S
    Goldmann, B
    Duchstein, HJ
    Berger, J
    Helmchen, U
    Freeman, BA
    Meinertz, T
    Münzel, T
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (06) : 902 - 911
  • [6] Influence of diabetes mellitus on heart failure risk and outcome
    Bauters, Christophe
    Lamblin, Nicolas
    Mc Fadden, Eugene P.
    Van Belle, Eric
    Millaire, Alain
    de Groote, Pascal
    [J]. CARDIOVASCULAR DIABETOLOGY, 2003, 2 (1)
  • [7] The effect of zinc supplementation on ghrelin-immunoreactive cells and lipid parameters in gastrointestinal tissue of streptozotocin-induced female diabetic rats
    Bolkent, S.
    Yanardag, R.
    Bolkent, S.
    Mutlu, O.
    Yildirim, S.
    Kangawa, K.
    Minegishi, Y.
    Suzuki, H.
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 286 (1-2) : 77 - 85
  • [8] Bonow Robert O., 2004, American Journal of Medicine, V116, p2S
  • [9] Peroxynitrite-induced α-actinin nitration and contractile alterations in isolated human myocardial cells
    Borbély, A
    Tóth, A
    Édes, I
    Virág, L
    Papp, JG
    Varró, A
    Paulus, WJ
    van der Velden, J
    Stienen, GJM
    Papp, Z
    [J]. CARDIOVASCULAR RESEARCH, 2005, 67 (02) : 225 - 233
  • [10] Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective
    Bradham, WS
    Bozkurt, B
    Gunasinghe, H
    Mann, D
    Spinale, FG
    [J]. CARDIOVASCULAR RESEARCH, 2002, 53 (04) : 822 - 830